Evidence map›Paper›PMID 22173215›Full record

ReviewLeukemia2012

Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development.

T C Luis, M Ichii, M H Brugman, P Kincade, F J T Staal

Open access · greenAbstract readReview
In one paragraph

Review in Leukemia, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 203 citations in OpenAlex.

  1. Article
  2. TIM-3 in AML: pathogenic roles and therapeutic targetability.Clinical and experimental medicine · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Detection of Cancer Stem Cells in Normal and Dysplastic/Leukemic Human Blood.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  10. Review
  11. The antitumor effects of WNT5A against hematological malignancies.Journal of cell communication and signaling · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

T C LuisDepartment of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
M Ichii
M H Brugman
P Kincade
F J T Staal
Erasmus MC · NLOklahoma Medical Research Foundation · USLeiden University Medical Center · NL

Funding

EARLY EVENTS IN MAMMALIAN B-CELL DIFFERENTIATION.R01AI020069 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KINCADE, PAUL WAYNE · 1985 to 2012
$5.2M
EARLY EVENTS IN MAMMALIAN B-CELL DIFFERENTIATIONR37AI020069 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KINCADE, PAUL WAYNE · 1989 to 1996
–
NIAID NIH HHS AI20069NIAID NIH HHS R01 AI020069Worldwide Cancer Research 07-0049
6 · The paper itself

Abstract

A strict balance between self-renewal and differentiation of hematopoietic stem cells (HSCs) is required in order to maintain homeostasis, as well as to efficiently respond to injury and infections. Numbers and fate decisions made by progenitors derived from HSC must also be carefully regulated to sustain large-scale production of blood cells. The complex Wnt family of molecules generally is thought to be important to these processes, delivering critical signals to HSC and progenitors as they reside in specialized niches. Wnt proteins have also been extensively studied in connection with malignancies and are causatively involved in the development of several types of leukemias. However, studies with experimental animal models have produced contradictory findings regarding the importance of Wnt signals for normal hematopoiesis and lymphopoiesis. Here, we will argue that dose dependency of signaling via particular Wnt pathways accounts for much, if not all of this controversy. We conclude that there seems little doubt that Wnt proteins are required to sustain normal hematopoiesis, but are likely to be presented in carefully controlled gradients in a tissue-specific manner.

Indexed as

Wnt Signaling PathwayAnimalsHematopoiesisHematopoietic Stem CellsHumansLeukemiaLigandsMiceSignal TransductionStem Cell NicheWnt ProteinsLigandsWnt Proteins

Identifiers

PMID22173215
PMCPMC3378318
OpenAlexW2071781451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.